Share on StockTwits

Immucell Corp (NASDAQ:ICCC) Director Jonathan E. Rothschild acquired 3,000 shares of the company’s stock in a transaction dated Wednesday, August 20th. The shares were purchased at an average cost of $4.55 per share, for a total transaction of $13,650.00. Following the acquisition, the director now directly owns 513,436 shares in the company, valued at approximately $2,336,134. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Immucell Corp (NASDAQ:ICCC) opened at 4.70 on Tuesday. Immucell Corp has a one year low of $3.30 and a one year high of $5.30. The stock has a 50-day moving average of $4.63 and a 200-day moving average of $4.41. The company’s market cap is $14.2 million.

Immucell Corp (NASDAQ:ICCC) last announced its earnings results on Tuesday, August 12th. The company reported ($0.10) earnings per share (EPS) for the quarter. The company had revenue of $1.54 million for the quarter, compared to the consensus estimate of $1.37 million.

ImmuCell Corporation creates scientifically proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries.

Receive News & Ratings for Immucell Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immucell Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.